| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-11 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-10 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-10 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-09 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |